About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD35.50
- USD36.30
- USD35.13
- USD62.58
- -35.20%
- 33M
- 3.20M
- 1.16M
- 2.2B
- 20.96
- 53.60%
- 3.10%
Stock News
3 hours ago
Cocoa’s the best-performing commodity in 2024 — and even beat bitcoin. What’s next.
MarketWatch
4 hours ago
BNP Paribas Signs €5.1 Billion Deal to Buy Axa’s Asset Manager
Yahoo
5 hours ago
The Returns At Cigna Group (NYSE:CI) Aren't Growing
Yahoo
6 hours ago
Billionaire Paul Tudor Jones' Fund Just Sold Boeing and Bought This Popular Cryptocurrency Instead
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
